Investors Sell Shares of St. Jude Medical Inc. (STJ) on Strength (STJ)
Investors sold shares of St. Jude Medical Inc. (NYSE:STJ) on strength during trading on Friday. $210.13 million flowed into the stock on the tick-up and $239.81 million flowed out of the stock on the tick-down, for a money net flow of $29.68 million out of the stock. Of all equities tracked, St. Jude Medical had the 0th highest net out-flow for the day. St. Jude Medical traded up $0.19 for the day and closed at $78.01
A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of St. Jude Medical in a report on Sunday, July 17th. Canaccord Genuity reiterated a “hold” rating on shares of St. Jude Medical in a research note on Saturday, April 30th. Wedbush lowered shares of St. Jude Medical from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $70.00 to $84.00 in a research note on Friday, July 15th. Wells Fargo & Co. reiterated a “hold” rating on shares of St. Jude Medical in a research note on Saturday, April 30th. Finally, Credit Suisse Group AG lowered shares of St. Jude Medical from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $67.00 to $81.00 in a research note on Tuesday, May 3rd. Twenty-two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. St. Jude Medical presently has an average rating of “Hold” and a consensus target price of $75.93.
The company has a 50-day moving average of $82.13 and a 200 day moving average of $69.87. The stock has a market cap of $22.23 billion and a PE ratio of 33.92.
St. Jude Medical (NYSE:STJ) last issued its earnings results on Wednesday, July 20th. The medical technology company reported $1.06 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.06. The firm earned $1.56 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the previous year, the company posted $1.07 EPS. The firm’s revenue for the quarter was up 10.8% on a year-over-year basis. Analysts expect that St. Jude Medical Inc. will post $4.06 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.59%. The ex-dividend date is Wednesday, September 28th.
A hedge fund recently raised its stake in St. Jude Medical stock. Dimensional Fund Advisors LP increased its stake in St. Jude Medical Inc. (NYSE:STJ) by 32.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 823,890 shares of the medical technology company’s stock after buying an additional 199,858 shares during the period. Dimensional Fund Advisors LP owned approximately 0.29% of St. Jude Medical worth $50,894,000 at the end of the most recent reporting period.
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.